Pastoors, D., Havermans, M., Mulet-Lazaro, R., Smeenk, L., Ottema, S., Erpelinck-Verschueren, C., Herk, S. V., Anthonissen, M., Grob, T., Subramanian, S., Thoms, J. A. I., Pimanda, J. E., Wouters, B. J., Beverloo, B., Haferlach, T., Haferlach, C., Zuber, J., Bindels, E., Delwel, R. (2025). MECOM is a master repressor of myeloid differentiation through dose control of
                    <i>CEBPA</i>
                    in acute myeloid leukemia. Blood. https://doi.org/10.1182/blood.2025028914